Trial Site Detail

 

Drug:
Sunitinib or Imatinib
Trial:
Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors (Resistant at 400 mg Imatinib)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Site name unknown, Bologna 40138

     
Bologna , 40138
Italy

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Site name unknown, Bologna 40138 Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.